Explore Clinical Trials

2,859 Canadian clinical trials, in plain language.

Recruiting Drug Device Behavioral Older adults Healthy volunteers

Lung Cancer →

106 trials matching “Lung Cancer” · showing 30

Testing Varying Doses of RT for transplant-related lung cancer

Explore this study →

One site, in Toronto

Recruiting

Official title: Non-ablative Oligofractionated Radiation Therapy Before Surgical Transplantation As Radiovaccination

Transplant-Related Lung Cancer · Marc de Perrot

Comparing Sevabertinib with Pembrolizumab for HER2 mutation advanced non-small cell lung cancer

Explore this study →

Sites in Brampton, Montreal and 2 more cities

RecruitingPHASE3

Official title: A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Advanced Non-small Cell Lung Cancer, HER2 Mutation · Bayer

Comparing 5 approaches for locally advanced or metastatic KRAS G12C-mutated non-small

Explore this study →

Sites in Montreal and Sherbrooke

RecruitingPHASE1

Official title: Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer · Novartis Pharmaceuticals

Get matched to the best-fit trials

Answer a few questions and we'll find the closest matches.

Comparing Calderasib with Pemetrexed for non-small cell lung cancer

Explore this study →

One site, in Edmonton

RecruitingPHASE3

Official title: A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

Non-small Cell Lung Cancer · Merck Sharp & Dohme LLC

Testing 225Ac-ETN029 with 111In-ETN029 for small cell lung carcinoma

Explore this study →

One site, in Montreal

RecruitingPHASE1

Official title: Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors

Small Cell Lung Carcinoma · Novartis Pharmaceuticals

Comparing Telisotuzumab Vedotin with Docetaxel for non small cell lung cancer

Explore this study →

Sites in Brampton, Edmonton and 3 more cities

RecruitingPHASE3

Official title: A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer · AbbVie

Testing Belimumab against a placebo for interstitial lung diseases

Explore this study →

Sites in Montreal and Trois-Rivières

RecruitingPHASE3

Official title: A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

Lung Diseases, Interstitial · GlaxoSmithKline

Comparing Pumitamig with Pembrolizumab for non-small cell lung cancer (NSCLC)

Explore this study →

Sites in Halifax, Oshawa and 3 more cities

RecruitingPHASE3

Official title: A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Non-Small Cell Lung Cancer (NSCLC) · Bristol-Myers Squibb

Comparing Pumitamig with Durvalumab for non-small cell lung cancer (NSCLC)

Explore this study →

Sites in Montreal, Ottawa and 1 more city

RecruitingPHASE3

Official title: A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Non-small Cell Lung Cancer (NSCLC) · Bristol-Myers Squibb

Comparing Divarasib with Pemetrexed for non-small cell lung cancer

Explore this study →

Sites in Barrie, Brampton and 7 more cities

RecruitingPHASE3

Official title: A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer · Hoffmann-La Roche

Comparing Calderasib with Pembrolizumab for non-small cell lung cancer

Explore this study →

Sites in Halifax, Hamilton and 4 more cities

RecruitingPHASE3

Official title: A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

Non-small Cell Lung Cancer · Merck Sharp & Dohme LLC

Testing LY3537982 against a placebo for non-small-cell lung carcinoma

Explore this study →

Sites in Abbotsford British Columbia, Chicoutimi and 1 more city

RecruitingPHASE3

Official title: A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung · Eli Lilly and Company

Comparing 4 approaches for non-small cell lung cancer

Explore this study →

Sites in Montreal, Ottawa and 1 more city

RecruitingPHASE1

Official title: A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation

Non-Small Cell Lung Cancer · Hoffmann-La Roche

Testing Tozorakimab against a placebo for viral lung infection and acute respiratory failure

Explore this study →

Sites in Montreal, Winnipeg and 8 more cities

RecruitingPHASE3

Official title: Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

Viral Lung Infection and Acute Respiratory Failure · AstraZeneca

Testing Mycophenolate Mofetil against a placebo for systemic sclerosis with lung involvement

Explore this study →

Sites in Montreal and Québec

RecruitingPHASE2

Official title: Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease

Systemic Sclerosis With Lung Involvement · Centre hospitalier de l'Université de Montréal (CHUM)

Comparing 3 approaches for fibrosing interstitial lung disease

Explore this study →

Sites in Calgary and Toronto

RecruitingPHASE3

Official title: A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)

Fibrosing Interstitial Lung Disease · Boehringer Ingelheim

Comparing Exertional Oxygen with Education and Support for fibrotic interstitial lung disease

Explore this study →

One site, in Edmonton

RecruitingPHASE2

Official title: Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease

Fibrotic Interstitial Lung Disease · University of Alberta

Testing Chest CT Scan for lung cancer

Explore this study →

One site, in Vancouver

Recruiting

Official title: Improving Detection of Early Lung Cancer in a Diverse Population (IDEAL) Study

Lung Cancer · British Columbia Cancer Agency

Testing Oxaliplatin for lung metastases

Explore this study →

One site, in Toronto

RecruitingPHASE1

Official title: In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung

Lung Metastases · University Health Network, Toronto

Comparing 3 approaches for lung cancer

Explore this study →

One site, in Saskatoon

RecruitingPHASE1

Official title: Evaluation of 89Zr-DFO-nimotuzumab for Non-invasive Imaging of EGFR+ Cancers by Positron Emission Tomography (PET)

Lung Cancer · University of Saskatchewan

Testing Prehabilitation for neoplasm of lung

Explore this study →

One site, in Halifax

Recruiting

Official title: Prehab for Lung and Esophageal Cancer

Neoplasm of Lung · Nova Scotia Health Authority

Testing Vitamin D3 Drops with Coriolus Versicolor for lung cancer

Explore this study →

Sites in Ottawa and Toronto

RecruitingPHASE3

Official title: The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III

Lung Cancer · Ottawa Hospital Research Institute

Comparing Lazertinib with Carboplatin for non-small-cell lung carcinoma

Explore this study →

One site, in Toronto

RecruitingPHASE2

Official title: A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC

Carcinoma, Non-Small-Cell Lung · Janssen Research & Development, LLC

Comparing Calderasib with MK-3475A for non-small cell lung cancer

Explore this study →

Sites in Moncton and Montreal

RecruitingPHASE3

Official title: MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)

Non-small Cell Lung Cancer · Merck Sharp & Dohme LLC

Testing Trastuzumab Deruxtecan for non-small cell lung cancer

Explore this study →

One site, in Montreal

RecruitingPHASE2

Official title: A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer · Memorial Sloan Kettering Cancer Center

Comparing Amivantamab with Olomorasib for non-small-cell lung carcinoma

Explore this study →

One site, in Toronto

RecruitingPHASE1

Official title: A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung · Janssen Research & Development, LLC

Comparing Ris-Rez with Topotecan for lung neoplasms

Explore this study →

Sites in Montreal, Ottawa and 1 more city

RecruitingPHASE3

Official title: A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)

Neoplasms, Lung · GlaxoSmithKline

Comparing 7 approaches for non-squamous non-small cell lung cancer

Explore this study →

Sites in Ottawa and Toronto

RecruitingPHASE2

Official title: A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Non-Squamous Non-Small Cell Lung Cancer · AbbVie

Comparing Sacituzumab Govitecan (SG) with Topotecan for extensive stage small cell lung cancer (ES-SCLC)

Explore this study →

Sites in Barrie, Hamilton and 3 more cities

RecruitingPHASE3

Official title: Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

Extensive Stage Small Cell Lung Cancer (ES-SCLC) · Gilead Sciences

Comparing Sigvotatug Vedotin with Pembrolizumab for non-small cell lung cancer

Explore this study →

Sites in Saint-Jérôme, Abbotsford British Columbia and 1 more city

RecruitingPHASE3

Official title: This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Non-Small Cell Lung Cancer · Pfizer

Looking for the closest fit?

Get matched →

Get notified when a matching trial opens

We'll watch for Lung Cancer trials near you.

Concord provides information support only. Trial listings come from public registries; eligibility is always determined by the trial site and your care team.